1339 related articles for article (PubMed ID: 26219858)
21. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
Younossi ZM
Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
[TBL] [Abstract][Full Text] [Related]
22. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
23. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
Crespo M; Lappe S; Feldstein AE; Alkhouri N
Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
Yilmaz Y; Eren F
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
Westfall E; Jeske R; Bader AR
Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
27. APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE.
Mikolašević I; Orlić L; Štimac D; Mavrinac V; Colić M; Ostojić D; Milić S
Lijec Vjesn; 2016 May; 138(5-6):159-163. PubMed ID: 29182828
[TBL] [Abstract][Full Text] [Related]
28. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).
Drescher HK; Weiskirchen S; Weiskirchen R
Cells; 2019 Aug; 8(8):. PubMed ID: 31394730
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
Gracious BL; Bhatt R; Potter C
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
Tokushige K; Ikejima K; Ono M; Eguchi Y; Kamada Y; Itoh Y; Akuta N; Yoneda M; Iwasa M; Yoneda M; Otsuka M; Tamaki N; Kogiso T; Miwa H; Chayama K; Enomoto N; Shimosegawa T; Takehara T; Koike K
J Gastroenterol; 2021 Nov; 56(11):951-963. PubMed ID: 34533632
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
32. Role of liver biopsy in nonalcoholic fatty liver disease.
Nalbantoglu IL; Brunt EM
World J Gastroenterol; 2014 Jul; 20(27):9026-37. PubMed ID: 25083076
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
Schild MH; Guy CD
Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874
[TBL] [Abstract][Full Text] [Related]
34. The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease.
Isabela Andronescu C; Roxana Purcarea M; Aurel Babes P
J Med Life; 2018; 11(3):243-246. PubMed ID: 30364513
[TBL] [Abstract][Full Text] [Related]
35. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
Polanco-Briceno S; Glass D; Stuntz M; Caze A
BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
[TBL] [Abstract][Full Text] [Related]
36. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
Castera L
Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic Fatty Liver Disease.
Sweet PH; Khoo T; Nguyen S
Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
[TBL] [Abstract][Full Text] [Related]
39. Liver Disease: Nonalcoholic Fatty Liver Disease.
Cooper J; Baumgartner K; Smith A; St Louis J
FP Essent; 2021 Dec; 511():29-35. PubMed ID: 34855339
[TBL] [Abstract][Full Text] [Related]
40. [An Overview of NAFLD/NASH in Japan].
Kim SR; Kim KI
Yakugaku Zasshi; 2016; 136(4):565-72. PubMed ID: 27040340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
